MATULANE (procarbazine HCl)
PROCARBAZINE · HODGKIN'S LYMPHOMA
LEADIANT BIOSCI
Drug class
Procarbazine
Procarbazine is a specific antineoplastic active ingredient rather than a standalone therapeutic class; pharmacologically, it belongs to the nonclassic alkylating agent and hydrazine derivative drug classes. Read more about Procarbazine
1 drugs in this class 1 manufacturers
Drugs in Procarbazine
Filter & compare in the drug finder →
Opens the drug finder with Procarbazine preselected. Add indication or manufacturer filters there.
Procarbazine is a specific antineoplastic active ingredient rather than a standalone therapeutic class; pharmacologically, it belongs to the nonclassic alkylating agent and hydrazine derivative drug classes.
It undergoes hepatic biotransformation to produce reactive intermediates that methylate DNA, suppress nucleic acid and protein synthesis, and trigger cytotoxicity.
Clinically, it is primarily utilized as an oral component of combination chemotherapy regimens for advanced Hodgkin lymphoma and central nervous system neoplasms, such as oligodendrogliomas and astrocytomas.
-
cancer.gov
Procarbazine is a specific antineoplastic active ingredient rather than a standalone therapeutic class; pharmacologically, it belongs to the nonclassic alkylating agent and hydrazine derivative drug classes
-
nih.gov
Procarbazine is a specific antineoplastic active ingredient rather than a standalone therapeutic class; pharmacologically, it belongs to the nonclassic alkylating agent and hydrazine derivative drug classes
-
cancer.gov
It undergoes hepatic biotransformation to produce reactive intermediates that methylate DNA, suppress nucleic acid and protein synthesis, and trigger cytotoxicity
-
cancer.gov
It undergoes hepatic biotransformation to produce reactive intermediates that methylate DNA, suppress nucleic acid and protein synthesis, and trigger cytotoxicity
-
fda.gov
Clinically, it is primarily utilized as an oral component of combination chemotherapy regimens for advanced Hodgkin lymphoma and central nervous system neoplasms, such as oligodendrogliomas and astrocytomas
-
cancer.gov
Clinically, it is primarily utilized as an oral component of combination chemotherapy regimens for advanced Hodgkin lymphoma and central nervous system neoplasms, such as oligodendrogliomas and astrocytomas
-
nih.gov
Clinically, it is primarily utilized as an oral component of combination chemotherapy regimens for advanced Hodgkin lymphoma and central nervous system neoplasms, such as oligodendrogliomas and astrocytomas
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.